Exact Mass: 369.1123

A dibenzazecine alkaloid that is protopine bearing a hydroxy substituent at the 6-position.

Corpaine

Corysolidine, (+)

Ochratoxin B

2-{[hydroxy(8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl)methylidene]amino}-3-phenylpropanoic acid

Ochratoxin B is a metabolite of Aspergillus ochraceu

Isorheagenine

13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2(10),3,8,15(23),16,18(22)-hexaen-24-ol

Rhoeagenine is an alkaloid from Papaver rhoeas (corn poppy

2-Chloro-N6-cyclopentyladenosine

2-[2-chloro-6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

Etofenamate

2-(2-Hydroxyethoxy)-ethyl-N-(alpha,alpha,alpha-trifluoro- m-tolyl)anthranilate

C18H18F3NO4 (369.1188)

M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Taspine

5-[2-(dimethylamino)ethyl]-7,14-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

Papaverrubin A

N-Demethylisorheadine

Cassythic acid

(+)-Cassythic acid

5,6,7,7a-Tetrahydro-10-hydroxy-11-methoxy-8H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline-7-carboxylic acid methyl ester

(-)-O7-demethyl-adlumine|(R)-6-((R)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-1-yl)-6H-furo[3,4:3,4]benzo[1,2-d][1,3]dioxol-8-one|severcine|Severtzin|severtzine

(+/-)-noradlumine|adlumine

Ara-C triacetate

Taxilamine

Polyberbine

10-Hydroxychelidonine

axinyssimide B|axinyssimide C

C16H26Cl3NO2 (369.1029)

cornigerine

C20H19NO6

1,8-dihydroxy-6-(hydroxymethyl)-3-methoxy-2-(pyrrolidinium-2-yl) anthraquinone

N-Formylduguevanine

Coryximine

corphthaline

dioxindole-3-acetyl-3-O-beta-glucose

7-hydroxy-2-oxindole-3-acetate glucoside

NCGC00180546-03

NCGC00180546-03!

2-Chloro-N6-cyclopentyladenosine

2-Chloro-N(6)-cyclopentyladenosine

ccpa

2-Chloro-N6-cyclopentyladenosine

CCPA (2-Chloro-N6-cyclopentyladenosine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

MMV032967

C19H14N5F3 (369.1201)

OCHRATOXIN B

2-[(8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl)formamido]-3-phenylpropanoic acid

A phenylalanine derivative resulting from the formal condensation of the amino group of L-phenylalanine with the carboxy group of (3R)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid. Ochratoxin B differs from the more naturally abundant ochratoxin A in the absence of the dihydroisocoumarin chlorine atom. It has cytotoxic effects on kidney and liver cells in vitro but only minor effects in vivo, due to its rapid metabolism and excretion. It inhibits cell proliferation of human liver HepG2 cells at doses as low as 1 mug/ ml but lacks the genotoxic activity of ochratoxin A, even at higher concentrations. D009676 - Noxae > D011042 - Poisons > D009793 - Ochratoxins D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Penicillium verrucosum

Lys-Asp-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)pentanedioic acid

Asp-Lys-OH

(S)-7-amino-2-(3-(carboxymethoxy)-4-nitrobenzamido)heptanoic acid

Thaspine

Isorheagenine

13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0^{2,10}.0^{4,8}.0^{15,23}.0^{18,22}]pentacosa-2,4(8),9,15,17,22-hexaen-24-ol

Fmoc-D-Glu-OH

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-(15N)glutamic acid

Fmoc-Asp-Ome

alpha,alpha-bis[4-(dimethylamino)phenyl]-4-(ethylamino)naphthalene-1-methanol

4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole

C17H19BF3NO2S (369.1182)

4-(TERT-BUTOXYCARBONYLAMINO)-1-[(6-BROMOPYRIDIN-2-YL)METHYL]PIPERIDINE

C16H24BrN3O2 (369.1052)

Fmoc-Ser(Ac)-OH

Fmoc-Glu-OH

8,14-Dihydro-14-methyl-11-(trifluoromethyl)-indolo[2,3:3,4]pyrido[2,1-b]quinazolin-5(7H)-one

C20H14F3N3O (369.1089)

(+)-Egenine

Fmoc-Asp(OMe)-OH

ethyl 4,5-bis(4-methoxyphenyl)-1,3-thiazole-2-carboxylate

C20H19NO4S (369.1035)

Fmoc-D-Asp-OMe

Azaphen

C16H21Cl2N5O (369.1123)

1,1,2,3-tetramethyl-1H-benzo[e]indolium hexafluorophosphate(V)

C16H18N.F6P (369.1081)

(+)-Corlumidine

1-(anthracen-9-ylmethyl)-4-(2-chlorophenyl)triazole

C23H16ClN3 (369.1033)

2-[(8-Hydroxy-3-methyl-1-oxoisochroman-7-carbonyl)amino]-3-phenylpropionic acid

(2,5-dioxopyrrolidin-3-yl) N-[(4-methoxyphenyl)methyl]-N-phenylcarbamimidothioate

JWH 203 N-pentanoic acid metabolite

C21H20ClNO3 (369.1132)

N-(4-{2-[(3-Chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide

C20H20ClN3S (369.1066)

Etofenamate

C18H18F3NO4 (369.1188)

N-(pyridin-4-ylmethyl)-2-[3-(trifluoromethyl)phenyl]-1H-imidazo[4,5-c]pyridin-4-amine

C19H14F3N5 (369.1201)

7-(beta-D-glucosyloxy)-2-oxindole-3-acetic acid

2-[2-oxo-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetic acid

2-[2-oxo-3-[(2S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetic acid

N-(2,4-dimethylphenyl)sulfonyl-2-(1-naphthalenyloxy)acetamide

C20H19NO4S (369.1035)

N-[5-(dimethylsulfamoyl)-2-methylphenyl]-2-quinolinecarboxamide

N-[3-(dimethylsulfamoyl)-4-methylphenyl]-2-quinolinecarboxamide

5-(4-Fluorophenyl)sulfonyl-1-(2-methylpropyl)-4-nitro-2-propan-2-ylimidazole

C16H20FN3O4S (369.1158)

5-(dimethylamino)-N-(4-nitrosobenzyl)naphthalene-1-sulfonamide

Erdasporine A

C22H15N3O3 (369.1113)

A organic heterohexacyclic compound that is 12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole in which the hydrogens at positions 5 and 10 are substituted by a methoxycarbonyl and hydroxy groups, respectively. It is synthesized by a gene cluster found in environmental DNA and exhibits cytotoxic activity against human HCT116 cancer cells and Staphylococcus aureus.

Erdasporine C

C22H15N3O3 (369.1113)

An organic heterohexacyclic compound that is 6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole in which the hydrogens at positions 5 and 7 are substituted by a methoxycarbonyl and oxo groups, respectively. It is synthesized by a gene cluster found in environmental DNA and exhibits cytotoxic activity against human HCT116 cancer cells and Staphylococcus aureus.

7-hydroxy-2-oxindole-3-acetic acid beta-D-glucoside

A member of the class of oxindoles that is 7-hydroxy-2-oxindole-3-acetic acid in which the phenolic hydrogen has been replaced by a beta-D-glucosyl residue.

LPE 8:2;O2

C13H24NO9P (369.1189)

(1s,14r,24s)-24-methoxy-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15,17,22-hexaene

(1r,14r,24s)-13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15(23),16,18(22)-hexaen-24-ol

n-{5-hydroxy-14-methoxy-6-oxo-16,18-dioxatetracyclo[10.7.0.0²,⁸.0¹⁵,¹⁹]nonadeca-1(12),2,4,7,13,15(19)-hexaen-9-yl}ethanimidic acid

(7r,8r)-7',8-dihydroxy-6'-methoxy-2'-methyl-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-6-one

(1r,14s,24s)-13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15(23),16,18(22)-hexaen-24-ol

(2s)-2-({hydroxy[(3r)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-2-benzopyran-7-yl]methylidene}amino)-3-phenylpropanoic acid

10-hydroxychelidonine

{"Ingredient_id": "HBIN000139","Ingredient_name": "10-hydroxychelidonine","Alias": "NA","Ingredient_formula": "C20H19NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15818","TCMID_id": "9902","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

119736-65-1

(6S,8R)-6-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,8-dihydrofuro[4,3-g][1,3]benzodioxol-8-ol